XPOF runs five boutique fitness franchise brands. Club Pilates is the crown jewel — 1,241 NA studios, ≈65% of system-wide sales, $102M standalone EBITDA in 2024. A formal strategic review (Jefferies) was announced April 6 after activist letters from Voss Capital (19.3%) and Kanen Wealth (4%) urged a sale. Short interest 26.7%, RSI 17.2, 18% of 52-week range.

What the call said

The Q1 2026 earnings call (May 7) was a Reg FD blackout. CFO Robert Julian: "We are actively engaged in the company's recently announced review of strategic alternatives. We will not be addressing questions regarding that initiative." No analyst pressed.

Operational picture:

• Q1 Adj EBITDA $20.4M (-25% YoY); revenue $60.7M (-21%). 2026 guidance reiterated $100-110M Adj EBITDA, $260-270M revenue. Back-end weighted.
• Total NA SSS -6.2%; Club Pilates SSS -4%.
• Member retention +36bps YoY, March best since Q1 2024, 3-year LTV $2,300+. New cohorts "just seem to be getting a little bit better than the previous one" (Nuzzo).
• Two franchisees signed for ≈160 future Club Pilates studios; first studios opened in Mexico, Belgium, Thailand. 499+ committed international licenses.
• FDD 2026 renewal completed April — franchise sales resumed.
• Cash $21.5M unrestricted + $12.2M restricted; $10M revolver drawn April "out of an abundance of caution"; $24.4M legal/lease commitments remain in 2026.
• Interim CFO Julian explicitly framing his role as bridge to permanent CFO. New CMO from Shake Shack joining mid-May.
• USAO investigation (Central District California, open since May 2024): zero mention. Twelve months without update.

The diagnostic: retention improving while SSS declining means the brand is healthy and the customer acquisition funnel is broken. These are different problems with different implications for an acquirer.

What the market thinks

Stock $5.12, down 30% in a month. Analyst mean target $7.19 (1 Buy, 9 Hold, 0 Sell). Raymond James downgraded Strong Buy → Market Perform on March 19. P/C OI 0.07 (calls 14.6× puts); $8 July call OI 1,764 contracts, delta 0.16. ATM IV 90% (IV rank 46% — not at lows, but not pricing binary either). Market-implied probability of stock above $8 by July 17: ≈15-18%.

Standalone valuation math (2026 EBITDA $105M × 6-8× EBITDA = $630-840M EV, less $491M net debt, 59M shares): $2.35-5.91/share, midpoint ≈$4. Market is paying roughly standalone value plus a thin M&A option premium.

Probability-weighted forward E[r] from market positioning: ~+15-25% over 12 months.

The gap

Club Pilates standalone generated $102M EBITDA in 2024 (2025 Analyst Day). Entire company 2026 Adj EBITDA guidance midpoint is $105M — the other four brands plus corporate overhead net to roughly zero. At a 10-12× multiple for Club Pilates alone: $1.0-1.2B EV, equity $560-810M, $9.49-13.73/share versus current $5.12.

Why hasn't this priced:

• Sell-side coverage is dead. 1 Buy out of 10 analysts. Two analysts on the Q1 call. Targets don't break out Club Pilates standalone.
• Reg FD blackout suppresses information flow during the live Jefferies process.
• The USAO investigation is priced as a permanent overhang. Market gives declination zero weight despite SEC closing without action in July 2025.
• Q1 SSS weakness is being misread as thesis-broken rather than channel-broken. The retention diagnostic isn't in any analyst model.
• The driver of the SSS weakness (Meta Andromeda + Google AI Overviews) was independently named by 8+ companies in Q1 2026 calls — confirmed sectoral. Centralization of 3,000 fragmented studio Meta accounts is an operational lever only a strategic acquirer can pull. The market hasn't synthesized this cross-ticker pattern.

Forward E[r] from the analyst-built scenario: roughly +35-50% over 12 months. The mispricing is concentrated in the magnitude of the deal premium, not the probability of a deal.

Risks (ranked)

1. USAO escalates to company-level charges — deal terminates, equity approaches zero. Twelve-month black box; no information edge possible.
2. Cash compression accelerates — $33.7M cash against $24.4M committed legal/lease + $55M annual interest. Additional revolver draws signal EBITDA slipping and force distressed-seller dynamics on the auction, potentially compressing sale price 10-30%.
3. AI funnel disruption durable past sale window — Q2 SSS deteriorates, back-half guidance cut, multiple compresses for any standalone outcome. Mitigation is multi-quarter.
4. Process terminates without acceptable bid — Jefferies fails to find a buyer; stock reverts to ≈$4 standalone area.
5. Cohort multi-seller compression — subscale-software targets (DOMO, BL, DRIO, MATW, SODI) transacting same window compresses comp multiples. XPOF is asset-light franchisor not SaaS, but PE buyer universe overlaps.

Catalysts

• June-July 2026: Jefferies first-round bid indications (typical 60-90 days post-launch April 6)
• August 6, 2026: Q2 earnings — SSS, revolver, guidance
• By end 2026: USAO resolution deadline (set probability ≈50%)
• Q4 2026 / early 2027: Definitive agreement window if process on 4-8mo timeline
• Unscheduled: 8-K Item 1.01 with named bidder; Voss 13D/A amendment; Form 4 Code P insider cluster

What would change our mind

More bullish: USAO declination disclosed; 8-K naming a bidder; Voss 13D/A adding shares; Form 4 Code P cluster from director or interim CFO; Q2 Club Pilates SSS turns positive.

More bearish: Additional revolver draw before Q2 print; Q2 Club Pilates SSS worse than -4% with no mitigation evidence; interim CFO appointed permanent; AI funnel disruption confirmed durable across 2+ peer quarters.

Hard exit: USAO company-level charges; 8-K terminating process; covenant breach or going-concern flag.

Evidence

LR signal: 1.4 (bullish — market materially underweighting the magnitude of the crown-jewel breakout valuation, with directionally appropriate but smaller weight on deal probability)